AAPL353.05+1.14 (+0.32%) ▲|ABBV288.14-4.68 (-1.60%) ▼|ABT104.38-0.33 (-0.32%) ▼|ACN232.36-6.93 (-2.89%) ▼|ADBE225.78-9.77 (-4.15%) ▼|AMAT347.16-2.07 (-0.59%) ▼|AMD507.16+3.75 (+0.74%) ▲|AMGN446.85-11.08 (-2.42%) ▼|AMT180.95-2.24 (-1.22%) ▼|AMZN264.25+6.36 (+2.46%) ▲|AVGO351.58+9.98 (+2.92%) ▲|AXP314.75-1.04 (-0.33%) ▼|BA162.36-1.56 (-0.95%) ▼|BAC48.92-0.52 (-1.05%) ▼|BKNG153.95-0.51 (-0.33%) ▼|BLK1,178.76-1.92 (-0.16%) ▼|BMY60.06-1.29 (-2.10%) ▼|BNY149.10-0.70 (-0.46%) ▼|BRK-B577.38-9.38 (-1.60%) ▼|C117.98-1.96 (-1.63%) ▼|CAT554.35-16.44 (-2.88%) ▼|CL98.72-0.89 (-0.89%) ▼|CMCSA25.19-0.12 (-0.47%) ▼|COF185.34-1.44 (-0.77%) ▼|COP135.34-4.15 (-2.97%) ▼|COST1,103.32-6.76 (-0.61%) ▼|CRM187.03-7.49 (-3.85%) ▼|CSCO95.58+0.47 (+0.49%) ▲|CVS82.98-2.83 (-3.30%) ▼|CVX207.34-7.01 (-3.27%) ▼|DE647.26-1.97 (-0.30%) ▼|DHR226.42+0.65 (+0.29%) ▲|DIS119.77+2.83 (+2.42%) ▲|DUK129.45-0.39 (-0.30%) ▼|EMR160.43+1.28 (+0.80%) ▲|FDX319.43-0.51 (-0.16%) ▼|GD347.47-8.16 (-2.29%) ▼|GE326.67+0.27 (+0.08%) ▲|GEV781.52+1.61 (+0.21%) ▲|GILD169.15-1.11 (-0.65%) ▼|GM83.88-0.18 (-0.21%) ▼|GOOG277.92+0.32 (+0.12%) ▲|GOOGL280.77+0.57 (+0.20%) ▲|GS869.04-8.48 (-0.97%) ▼|HD336.68-2.34 (-0.69%) ▼|HON220.07+1.11 (+0.50%) ▲|IBM230.19-0.91 (-0.39%) ▼|INTC53.64-1.54 (-2.78%) ▼|INTU311.96-8.83 (-2.75%) ▼|ISRG425.66-4.87 (-1.13%) ▼|JNJ275.68-3.02 (-1.08%) ▼|JPM326.22-3.74 (-1.13%) ▼|KO98.20-0.59 (-0.60%) ▼|LIN510.43-4.68 (-0.91%) ▼|LLY1,389.99-25.56 (-1.81%) ▼|LMT572.71-17.63 (-2.99%) ▼|LOW219.48-0.98 (-0.44%) ▼|LRCX208.24-2.45 (-1.16%) ▼|MA642.08-3.65 (-0.57%) ▼|MCD273.52-2.30 (-0.83%) ▼|MDLZ66.47-0.28 (-0.42%) ▼|MDT100.58-1.74 (-1.70%) ▼|META611.77-7.11 (-1.15%) ▼|MMM179.59-1.29 (-0.71%) ▼|MO76.69-0.78 (-1.00%) ▼|MRK139.68-3.69 (-2.57%) ▼|MS180.58-2.95 (-1.61%) ▼|MSFT503.01-3.23 (-0.64%) ▼|MU693.67-18.75 (-2.63%) ▼|NEE84.59+0.17 (+0.20%) ▲|NFLX59.69+0.01 (+0.02%) ▲|NKE36.65+0.80 (+2.22%) ▲|NOW89.94-2.97 (-3.19%) ▼|NVDA152.05-3.42 (-2.20%) ▼|ORCL114.30-0.70 (-0.61%) ▼|PEP142.13+0.11 (+0.08%) ▲|PFE28.16-0.32 (-1.11%) ▼|PG170.52-1.20 (-0.70%) ▼|PLTR154.64-1.92 (-1.23%) ▼|PM192.39-1.99 (-1.02%) ▼|QCOM161.97-4.70 (-2.82%) ▼|RTX194.92-3.08 (-1.56%) ▼|SBUX108.47+0.98 (+0.91%) ▲|SCHW92.48+0.64 (+0.70%) ▲|SO93.75+0.15 (+0.16%) ▲|SPG230.36+0.12 (+0.05%) ▲|T22.03-0.26 (-1.17%) ▼|TMO686.90+0.11 (+0.02%) ▲|TMUS163.59-4.32 (-2.57%) ▼|TSLA380.55+0.44 (+0.12%) ▲|TXN290.78-5.08 (-1.72%) ▼|UBER69.00+0.19 (+0.28%) ▲|UNH361.87-27.81 (-7.14%) ▼|UNP302.82+5.79 (+1.95%) ▲|UPS111.01+0.70 (+0.63%) ▲|USB58.63-0.55 (-0.93%) ▼|V416.37-0.40 (-0.10%) ▼|VZ45.91-0.02 (-0.04%) ▼|WFC81.41-1.28 (-1.55%) ▼|WMT125.98-1.55 (-1.21%) ▼|XOM162.13-5.09 (-3.04%) ▼|AAPL353.05+1.14 (+0.32%) ▲|ABBV288.14-4.68 (-1.60%) ▼|ABT104.38-0.33 (-0.32%) ▼|ACN232.36-6.93 (-2.89%) ▼|ADBE225.78-9.77 (-4.15%) ▼|AMAT347.16-2.07 (-0.59%) ▼|AMD507.16+3.75 (+0.74%) ▲|AMGN446.85-11.08 (-2.42%) ▼|AMT180.95-2.24 (-1.22%) ▼|AMZN264.25+6.36 (+2.46%) ▲|AVGO351.58+9.98 (+2.92%) ▲|AXP314.75-1.04 (-0.33%) ▼|BA162.36-1.56 (-0.95%) ▼|BAC48.92-0.52 (-1.05%) ▼|BKNG153.95-0.51 (-0.33%) ▼|BLK1,178.76-1.92 (-0.16%) ▼|BMY60.06-1.29 (-2.10%) ▼|BNY149.10-0.70 (-0.46%) ▼|BRK-B577.38-9.38 (-1.60%) ▼|C117.98-1.96 (-1.63%) ▼|CAT554.35-16.44 (-2.88%) ▼|CL98.72-0.89 (-0.89%) ▼|CMCSA25.19-0.12 (-0.47%) ▼|COF185.34-1.44 (-0.77%) ▼|COP135.34-4.15 (-2.97%) ▼|COST1,103.32-6.76 (-0.61%) ▼|CRM187.03-7.49 (-3.85%) ▼|CSCO95.58+0.47 (+0.49%) ▲|CVS82.98-2.83 (-3.30%) ▼|CVX207.34-7.01 (-3.27%) ▼|DE647.26-1.97 (-0.30%) ▼|DHR226.42+0.65 (+0.29%) ▲|DIS119.77+2.83 (+2.42%) ▲|DUK129.45-0.39 (-0.30%) ▼|EMR160.43+1.28 (+0.80%) ▲|FDX319.43-0.51 (-0.16%) ▼|GD347.47-8.16 (-2.29%) ▼|GE326.67+0.27 (+0.08%) ▲|GEV781.52+1.61 (+0.21%) ▲|GILD169.15-1.11 (-0.65%) ▼|GM83.88-0.18 (-0.21%) ▼|GOOG277.92+0.32 (+0.12%) ▲|GOOGL280.77+0.57 (+0.20%) ▲|GS869.04-8.48 (-0.97%) ▼|HD336.68-2.34 (-0.69%) ▼|HON220.07+1.11 (+0.50%) ▲|IBM230.19-0.91 (-0.39%) ▼|INTC53.64-1.54 (-2.78%) ▼|INTU311.96-8.83 (-2.75%) ▼|ISRG425.66-4.87 (-1.13%) ▼|JNJ275.68-3.02 (-1.08%) ▼|JPM326.22-3.74 (-1.13%) ▼|KO98.20-0.59 (-0.60%) ▼|LIN510.43-4.68 (-0.91%) ▼|LLY1,389.99-25.56 (-1.81%) ▼|LMT572.71-17.63 (-2.99%) ▼|LOW219.48-0.98 (-0.44%) ▼|LRCX208.24-2.45 (-1.16%) ▼|MA642.08-3.65 (-0.57%) ▼|MCD273.52-2.30 (-0.83%) ▼|MDLZ66.47-0.28 (-0.42%) ▼|MDT100.58-1.74 (-1.70%) ▼|META611.77-7.11 (-1.15%) ▼|MMM179.59-1.29 (-0.71%) ▼|MO76.69-0.78 (-1.00%) ▼|MRK139.68-3.69 (-2.57%) ▼|MS180.58-2.95 (-1.61%) ▼|MSFT503.01-3.23 (-0.64%) ▼|MU693.67-18.75 (-2.63%) ▼|NEE84.59+0.17 (+0.20%) ▲|NFLX59.69+0.01 (+0.02%) ▲|NKE36.65+0.80 (+2.22%) ▲|NOW89.94-2.97 (-3.19%) ▼|NVDA152.05-3.42 (-2.20%) ▼|ORCL114.30-0.70 (-0.61%) ▼|PEP142.13+0.11 (+0.08%) ▲|PFE28.16-0.32 (-1.11%) ▼|PG170.52-1.20 (-0.70%) ▼|PLTR154.64-1.92 (-1.23%) ▼|PM192.39-1.99 (-1.02%) ▼|QCOM161.97-4.70 (-2.82%) ▼|RTX194.92-3.08 (-1.56%) ▼|SBUX108.47+0.98 (+0.91%) ▲|SCHW92.48+0.64 (+0.70%) ▲|SO93.75+0.15 (+0.16%) ▲|SPG230.36+0.12 (+0.05%) ▲|T22.03-0.26 (-1.17%) ▼|TMO686.90+0.11 (+0.02%) ▲|TMUS163.59-4.32 (-2.57%) ▼|TSLA380.55+0.44 (+0.12%) ▲|TXN290.78-5.08 (-1.72%) ▼|UBER69.00+0.19 (+0.28%) ▲|UNH361.87-27.81 (-7.14%) ▼|UNP302.82+5.79 (+1.95%) ▲|UPS111.01+0.70 (+0.63%) ▲|USB58.63-0.55 (-0.93%) ▼|V416.37-0.40 (-0.10%) ▼|VZ45.91-0.02 (-0.04%) ▼|WFC81.41-1.28 (-1.55%) ▼|WMT125.98-1.55 (-1.21%) ▼|XOM162.13-5.09 (-3.04%) ▼|
13.3 C
New York
Wednesday, November 18, 2026
Press ReleasesFinanceGlenn Agre Continues to Grow Strategically with Addition of Antitrust and Affirmative Recovery Litigator Jon Corey

Glenn Agre Continues to Grow Strategically with Addition of Antitrust and Affirmative Recovery Litigator Jon Corey

Former McKool Smith litigator gives Glenn Agre capabilities few firms offer; Glenn Agre will partner with cutting-edge AI platform FluxCap to support its antitrust practice.

NEW YORK, Nov. 18, 2026 /PRNewswire/ — Glenn Agre Bergman & Fuentes LLP announced today that nationally recognized affirmative recovery litigator Jon Corey has joined the firm as a partner. Corey, who has recovered more than $25 billion for clients over his career, brings a high-value affirmative recovery practice in antitrust and healthcare litigation on behalf of companies, health systems and state attorneys general, and his arrival continues a year of strategic growth for the firm that has included expansions of its Structured Financial Products Litigation and Employment and Trade Secrets Litigation practices.

Jon Corey

Glenn Agre also announced an enterprise agreement with FluxCap, the AI-powered litigation platform founded by former U.S. Department of Justice antitrust leaders Jonathan Kanter and Doha Mekki. The firm is among FluxCap’s first law firm clients.

“Companies, creditors and investors often hold valuable claims they have never pursued, and Jon has built his career finding them and turning them into recoveries,” said Andrew Glenn, Glenn Agre’s managing partner. “Combined with our restructuring and claims trading practices, Jon gives our clients a single team that can find, value and pursue those claims. FluxCap is a force multiplier, letting that team operate with the scale and focus those cases demand.”

Corey joins from McKool Smith, where he was a principal. Before that, he was a longtime partner at Quinn Emanuel Urquhart & Sullivan, where he co-managed the Washington, D.C. office. His practice focuses on recovering losses from anticompetitive conduct, health insurer misconduct, and ERISA violations. He represents more than 20 companies and dozens of health systems that opted out of the $2.7 billion and $2.8 billion Blue Cross Blue Shield antitrust settlements, as well as dozens of out-of-network surgical practices in algorithmic price-fixing claims against MultiPlan (now Claritev) and major commercial insurers.

Most recently, he filed ERISA fiduciary claims against UnitedHealth Group on behalf of six major employers, alleging mismanagement of their self-funded health plans. He also represents corporate clients against the major pharmacy benefit managers and insulin manufacturers in the insulin pricing multidistrict litigation. For state attorneys general, he pursues claims against commercial health insurers for overbilling, plan mismanagement, and anticompetitive conduct.

Previously, Corey was trial counsel for the Federal Housing Finance Agency in its mortgage-backed securities litigation against major banks, including the $800 million judgment against Nomura and RBS that the Second Circuit affirmed. He also represented whistleblowers in a False Claims Act suit that produced a $100 million settlement with Horizon Blue Cross Blue Shield of New Jersey. Lawdragon has named Corey one of its 500 Leading Plaintiff Financial Lawyers each year since 2023.

“I joined Glenn Agre because I believe this is where complex litigation is headed: focused teams of experienced lawyers taking on high-value cases,” said Corey. “I found a firm that shares that vision, gives me the freedom to take on the cases my clients want to pursue and is investing in technology that will help me put decades of experience to work at a scale that once required a much larger team.”

Launched in October 2026, FluxCap was developed by former senior U.S. Department of Justice antitrust officials and engineers with experience at Palantir. Built for lawyers representing public and private plaintiffs in antitrust litigation, the platform connects the facts, law and strategy of a case, helping attorneys test theories, identify gaps in the evidence and litigate at scale. Its findings, citations and conclusions can be reviewed and audited, allowing lawyers to independently verify the results.

“We’ve known Jon for years, and we view him as not only one of the leading lawyers in his field but one of the most entrepreneurial and forward-thinking attorneys in the industry,” said Jonathan Kanter, co-founder of FluxCap. “Glenn Agre is a perfect example of the kind of firm we built FluxCap for: a team of exceptional lawyers, equipped to take on far larger opponents. We are delighted to be partnering with Jon and Glenn Agre.”

Founded in 2021 with seven lawyers, Glenn Agre has grown to nearly 50 lawyers. Based in Washington, D.C., Corey will be part of the firm’s Affirmative Recovery, Antitrust Litigation, Healthcare Litigation, and State Attorneys General Representation practices.

About Glenn Agre Bergman & Fuentes LLP

With offices in New York and San Francisco, Glenn Agre Bergman & Fuentes LLP is a premier litigation and trial firm with deep experience in affirmative recovery, bankruptcy and restructuring, complex commercial disputes, employment and trade secrets litigation, structured financial products litigation and white-collar defense and investigations. Known for handling high-stakes matters with rigor and creativity, the firm is entrusted with its clients’ most challenging matters. For more information, please visit glennagre.com.

About FluxCap

FluxCap is a deep legal tech company building technology to help lawyers reason through complex litigation. Its platform integrates three systems, Almanac, FluxFacts Engine and Vision Manager, to give lawyers a dynamic understanding of the law, evidence and strategy across an entire case. FluxCap was founded by Jonathan Kanter, former U.S. Assistant Attorney General for Antitrust, and Doha Mekki, former Acting Assistant Attorney General for Antitrust, and is backed by investors including Y Combinator, Bloomberg Beta, Burford Capital and Coalition Partners. Learn more at fluxcap.com.

Media Contact: Becky Bergman, becky@furiarubel.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/glenn-agre-continues-to-grow-strategically-with-addition-of-antitrust-and-affirmative-recovery-litigator-jon-corey-302944221.html

SOURCE Glenn Agre Bergman & Fuentes

Recent News